CAMRELIZUMAB vs CANAKINUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CAMRELIZUMAB vs CANAKINUMAB: Safety Overview
| Metric | CAMRELIZUMAB | CANAKINUMAB |
|---|---|---|
| Total FAERS Reports | 429 | 10,462 |
| Deaths Reported | 55 | 518 |
| Death Rate | 12.8% | 5.0% |
| Hospitalizations | 136 | 2,624 |
| Average Patient Age | 54.7 yrs | 28.8 yrs |
| % Female Patients | 44.6% | 55.8% |
| Manufacturer | N/A | Novartis Pharmaceuticals Corporation |
| Route | N/A | SUBCUTANEOUS |
| Marketing Status | N/A | Prescription |